Clinical Trial Update: Neoadjuvant Chemoradiotherapy Plus Surgery vs. Surgery Plus Adjuvant Therapy for ESCC [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating neoadjuvant chemoradiotherapy plus surgery versus surgery with adjuvant therapy for esophageal squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Yongtao Han | Conditions: Esophageal Squamous Cell Carcinoma (ESCC) | Phase 3 | Status: COMPLETED